Why do resistant bacteria succeed?

August 14, 2014
A summary of the source and geographic spread of six different lineages of S. enterica serovar Paratyphi A, including the dates when transmission occurred. Lineage sources, labelled A-F, are circled. Credit: DOI: 10.1073/pnas.1411012111

(Medical Xpress)—In two new studies, scientists use genome sequencing of worldwide samples to show that bacteria can take very different routes to becoming a successful disease. Researchers can use these large-scale approaches to track pathogen transmission patterns across the globe and therefore possibly to predict the emergence and spread of a new disease.

In one study of Streptococcus agalactiae, a cause of serious neonatal septicaemia and shock in new born babies, the team reported that the emergence of the was due in part to the acquisition of genes encoding resistance to the . Contrastingly, a separate study of the bacteria Salmonella enterica serovar Paratyphi A found that it was most likely environmental changes that were possibly associated with urbanisation that led to epidemics of typhoid fever in human populations over the 450-year history of the disease.

"We have developed systems for characterising the population structure of pathogens, and used these systems in two instances to yield different findings," says Professor Gordon Dougan, author from the Wellcome Trust Sanger Institute. "We were able to define the timeframe of the origin of two completely different infectious diseases, and in future we will be able to use this approach to identify and control emerging threats."

The first study revealed that S. agalactiae, or Group B Streptococcus (GBS), emerged as a disease in the 1960s not just because of previous under diagnosis, as originally thought, but as a result of the widespread use of , which was introduced in 1948. The overuse of this broad-spectrum antibiotic resulted in an evolutionary bottleneck, where the GBS populations gained , converting them from a harmless organism to a pathogen and enabling them to occupy a new niche in mothers and babies.

Tetracycline can also reduce the thousands of species of helpful microorganism living in the mother and child, collectively known as the microbiome, which might help control GBS disease. This research provides further insight into how a new infectious disease emerges, and it can be used to determine how a future threat could be prevented.

"This is possibly the earliest case of the emergence of a new disease that can be directly associated with antibiotic use," says Professor Gordon Dougan. "GBS causes a distressing infection of sepsis and meningitis seen in new born children that can result in severe illness and death, making it one of the most serious diseases in babies."

This study also highlights the need for targeted drugs to fight strains such as CC17, a particularly virulent strain of GBS responsible for the majority of meningitis cases in new born children. The data reveals that CC17 capitalised on becoming resistant to tetracycline and then other antibiotics, expanding rapidly in numbers and contributing to the increase of neonatal infections.

"The use of broad-spectrum antibiotics has led to the emergence of GBS disease," says Dr Mark Davies, co-first author and NHMRC Training Fellow at both the Sanger Institute and the University of Queensland, Australia. "By combining surveillance with the use of specific targeted antimicrobials, we can reduce the risk of a new disease emerging in the future whilst maintaining the normal protective microbial flora within us."

Using whole in a separate study of S. enterica serovar Paratyphi A, which causes , researchers discovered the disease emerged in humans about 450 years ago, and has remained genetically similar since then. Researchers revealed that Paratyphi A has undergone a gradual accumulation of mutations over time known as genetic drift, which has resulted in little change during its life as a pathogen. However, signatures of antibiotic resistance are now also emerging but they appear not to be stable at the moment.

This study is particularly timely because vaccines for Paratyphi A are currently being tested, and it is hoped that trials will start within two to three years. The research will help scientists to understand how the pathogen is moving between individuals and between populations, as well as how it is changing genetically over time. This will enable scientist to risk assess each vaccine trial site individually, and apply a tailored intervention programme that will be likely to have the most impact in that particular location.

The study also suggests that the disease may have moved from an animal source when humans started living in denser urban environments in close proximity to livestock. Similar to the history of whooping cough and tuberculosis, the pathogen then became fixed in humans and spread around the globe. Like the GBS study, this new research also suggests that Paratyphi A has begun to change genetically in recent decades through the use of antibiotics.

Explore further: Careless use of drugs bred baby-threatening germ, scientists report

More information: Transient Darwinian selection in Salmonella enterica serovar Paratyphi A during 450 years of global spread of enteric fever. Zhou Z, McCann A, Weill FX, Blin C, Nair S, Wain J, Dougan G and Achtman M, Proceedings of the National Academy of Sciences 2014. PUBMED: 25092320; DOI: 10.1073/pnas.1411012111

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, Ma L, Romi B, Tichit M, Lopez-Sanchez MJ, Descorps-Declere S, Souche E, Buchrieser C, Trieu-Cuot P, Moszer I, Clermont D, Maione D, Bouchier C, McMillan DJ, Parkhill J, Telford JL, Dougan G, Walker MJ, DEVANI Consortium, Holden MT, Poyart C, Glaser P and DEVANI Consortium, Nature communications 2014;5;4544. PUBMED: 25088811; DOI: 10.1038/ncomms5544

Related Stories

Careless use of drugs bred baby-threatening germ, scientists report

August 4, 2014
Careless use of a broad-spectrum antibiotic in the 1950s created a "hyper-virulent" strain of germ that worsened risks for newborn babies, according to detective work by French-led gene scientists.

Epidemic outbreaks caused by environment, not evolution

August 4, 2014
Researchers have traced genetic changes in a bacterial pathogen over 450 years, and claim that epidemics of bacterial disease in human history may be caused by chance environmental changes rather than genetic mutations.

New research has shown that the burden of meningitis in babies unchanged in 25 years

July 16, 2014
New research by Professor Paul Heath funded by Meningitis Research Foundation has shown that the burden of meningitis in babies under three months of age has changed little in the past 25 years.

New survey launched into Group B streptococcus infection in babies

April 2, 2014
Researchers have launched a national study to see how common the potentially fatal bacterial infection Group B streptococcus is in UK and Irish babies.

More accurate diagnostic test may reduce deaths

June 26, 2012
A more accurate, faster diagnostic test for Group B Streptococcal infection in babies has been reported in the Journal of Medical Microbiology. The new test could allow better treatment and management of the disease and reduce ...

Exchange of genetic material between harmless bacteria could be reservoir of antibiotic resistance

February 21, 2014
Researchers have found that a harmless bacterium could be a source for antibiotic resistance in treatments against such diseases as pneumonia, bacteraemia and meningitis. Their results could help in the design of better strategies ...

Recommended for you

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.